EIF4H expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.290200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.052600E-01
Normal-vs-Stage2
8.492600E-01
Normal-vs-Stage3
3.043200E-01
Normal-vs-Stage4
5.878400E-01
Stage1-vs-Stage2
6.728600E-01
Stage1-vs-Stage3
3.713400E-01
Stage1-vs-Stage4
1.797350E-01
Stage2-vs-Stage3
2.446400E-01
Stage2-vs-Stage4
3.754200E-01
Stage3-vs-Stage4
1.660620E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.487200E-01
Normal-vs-AfricanAmerican
9.392600E-01
Normal-vs-Asian
4.735000E-01
Caucasian-vs-AfricanAmerican
7.122000E-01
Caucasian-vs-Asian
1.111980E-01
AfricanAmerican-vs-Asian
3.064400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.428200E-01
Normal-vs-Female
8.154400E-01
Male-vs-Female
9.279200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.547400E-01
Normal-vs-Age(41-60Yrs)
5.259200E-01
Normal-vs-Age(61-80Yrs)
4.872200E-01
Normal-vs-Age(81-100Yrs)
9.280400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.630030E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.185600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.958200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.45379999996853E-06
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.858030E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.794200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.283800E-01
Normal-vs-Daily Drinker
6.533400E-01
Normal-vs-Weekly Drinker
5.659200E-01
Normal-vs-Occasional Drinker
6.398000E-01
Normal-vs-Social Drinker
9.948800E-01
Non Drinker-vs-Daily Drinker
9.839400E-01
Non Drinker-vs-Weekly Drinker
7.272400E-01
Non Drinker-vs-Occasional Drinker
1.413950E-01
Non Drinker-vs-Social Drinker
4.895400E-01
Daily Drinker-vs-Weekly Drinker
7.118400E-01
Daily Drinker-vs-Occasional Drinker
9.144200E-02
Daily Drinker-vs-Social Drinker
4.179400E-01
Weekly Drinker-vs-Occasional Drinker
7.647700E-02
Weekly Drinker-vs-Social Drinker
3.086000E-01
Occasional Drinker-vs-Social Drinker
4.277200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.923600E-01
Normal-vs-Grade 2
5.052600E-01
Normal-vs-Grade 3
3.011900E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.036200E-02
Grade 1-vs-Grade 3
4.603100E-03
Grade 1-vs-Grade 4
5.923600E-01
Grade 2-vs-Grade 3
6.932100E-02
Grade 2-vs-Grade 4
5.052600E-01
Grade 3-vs-Grade 4
3.011900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.827000E-01
Normal-vs-NonDiabetic
8.658200E-01
Diabetic-vs-NonDiabetic
2.831400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.964000E-01
Normal-vs-NoPancreatitis
7.507800E-01
Pancreatitis-vs-NoPancreatitis
9.732400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.869000E-01
Normal-vs-N1
8.532800E-01
N0-vs-N1
8.799200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.455600E-01
Normal-vs-TP53-NonMutant
6.279200E-01
TP53-Mutant-vs-TP53-NonMutant
7.322800E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
